Hospice Enrollment and Central Nervous System–Active Medication Prescribing to Medicare Decedents with Dementia-Reference-Cited by-同舟云学术

Hospice Enrollment and Central Nervous System–Active Medication Prescribing to Medicare Decedents with Dementia

Published:2024-09-01 Issue:9 Volume:81 Page:944
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Gerlach Lauren B.¹²,Zhang Lan¹,Teno Joan³,Maust Donovan T.¹²⁴

Affiliation:

1. Department of Psychiatry, University of Michigan Medical School, Ann Arbor

2. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor

3. Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island

4. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan

Abstract

This study explores the extent to which hospice enrollment is associated with CNS–active medication exposure among Medicare decedents with Alzheimer disease and related dementias.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2821273/jamapsychiatry_gerlach_2024_ld_240007_1724351325.21521.pdf

Reference6 articles.

1. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.;Gerlach;J Am Geriatr Soc,2021

2. Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US.;Maust;JAMA,2020

3. Validation of claims algorithms to identify Alzheimer’s disease and related dementias.;McCarthy;J Gerontol A Biol Sci Med Sci,2022

4. Factors associated with benzodiazepine and antipsychotic prescribing in hospice: a qualitative study of hospice prescribers.;Gerlach;J Am Med Dir Assoc,2023

5. Hospice improves care quality for older adults with dementia in their last month of life.;Harrison;Health Aff (Millwood),2022